
Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SEQUENT | BSE
0.17
0.14%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
30/11/2023
123.71
120.01
126.00
118.25
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics anti-protozoal nutraceuticals nonsteroidal anti-inflammatory drugs anti-infectives and dermatology. It offers analytical solutions that supports API pharmaceutical personal care and nutraceutical organizations as well as provides method validation stability and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
High Short-term Volatility
Smallcap (300M - 2B USD)
No Dividends (Dividend Yield = 0%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
49.6%1 month
42.2%3 months
48.4%6 months
47.2%0
33.33
3.11
0.73
0.31
33.23
1.89
0
207.49M
30.58B
366.90M
0
-5.93
-44.80
-2.40
-16.38
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
30.69
Range1M
31.29
Range3M
41.87
Rel. volume
0.88
Price X volume
31.78M